ownitsafely
Back to recalls

FDARecalled Nov 5, 2025 · #D-0100-2026

Duloxetine Delayed-Release Capsules, USP, 60 mg, a.) 90-count bottle (NDC: 51991-748-90), b.)1000-count bottle (NDC 51991-748-10),Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (B...

Hazard

Class II — temporary health risk

Be the first to hear about future recalls.

Add the things you own to a watchlist. We’ll alert you the moment one matches.

Get started, free

Description

CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment limit of 12.5ppm. Classification: Class II Distribution: U.S. Nationwide

Product details

Product
Duloxetine Delayed-Release Capsules, USP, 60 mg, a.) 90-count bottle (NDC: 51991-748-90), b.)1000-count bottle (NDC 51991-748-10),Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain; Dist. by: Breckenridge Pharmaceutical, Inc., Berkeley Heights, NJ 07922.
Type
Drugs
Manufacturer
Breckenridge Pharmaceutical, Inc.
Model numbers
240721C, 230286C
UPCs